WXSHC-071

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameWXSHC-071
Drug Alias NameWXSHC-071
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/glucose cotransporter 1 inhibitorsDipeptidyl peptidase IV inhibitorsSodium/glucose cotransporter 2 inhibitors
TargetsSodium/glucose cotransporter 1Sodium/glucose cotransporter 2Dipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesDongbao Zixing (Hangzhou) Biological Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesDongbao Zixing (Hangzhou) Biological Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A